Clinical Trials

132 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT06277674 2024-03-08

Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05011227 2024-03-06

Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma

100 enrolled

Nasopharyngeal Carcinoma

NCT03599960 2024-02-08

LpDessai

26 enrolled

Myeloid

Blastic Plasmacytoid Dendritic Cell Neoplasm

NCT05237349 2024-01-05

Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma

38 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT06170697 2023-12-20

Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma

46 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03620032 2023-12-06

DIPG

54 enrolled

CNS

Diffuse Intrinsic Pontine Glioma

NCT05935579 2023-11-15

Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

40 enrolled

Biliary Tract Neoplasms

NCT06120127 2023-11-07

IMPROVE

80 enrolled

Colorectal Neoplasms

NCT03742193 2023-11-01

PROACH

43 enrolled

Sarcoma

Osteosarcoma

NCT05128630 2023-09-28

DEDALUS

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04681287 2023-09-25

Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.

46 enrolled

Breast

HER2 Positive Metastatic Breast Cancer

NCT04653480 2023-07-17

Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC

61 enrolled

Colorectal Neoplasms

NCT02679040 2023-07-03

HIST-RIC

101 enrolled

Breast

Breast Neoplasms

NCT05868317 2023-05-22

Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer

70 enrolled

Rectal Neoplasms

NCT05844371 2023-05-06

Efficacy and Safety of Tirelizumab Plus Chemotherapy Versus Chemotherapy Alone in Patients With Lymph Node Positive Gastric Cancer After Surgery

60 enrolled

Stomach Neoplasms

NCT05842018 2023-05-03

Toripalimab in Combination With Chemotherapy and Antiangiogenic Agents in Patients With Non-Small Cell Lung Cancer After Failure of Immunotherapy (PD-1/L1 Inhibitors)

Non Small Cell Lung Cancer Recurrent

NCT04667793 2023-04-04

Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor

15 enrolled

Thymic epithelial tumor

NCT03975114 2023-03-24

MILES-5

460 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05541146 2023-03-23

Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis

GastrointestinalGynecologic

Carcinoma, Peritoneal Neoplasms, Stomach Neoplasms

NCT03803436 2023-03-16

COLT

22 enrolled

Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT05323890 2023-03-14

Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma.

15 enrolled

Advanced Esophageal Squamous Cell Cancer

NCT05549466 2023-02-08

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

84 enrolled

Nasopharyngeal Carcinoma

NCT05650216 2022-12-14

Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE-RT）

Esophageal Squamous Cell Carcinoma

NCT05621434 2022-11-18

A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer

63 enrolled

Breast

Breast Neoplasms

NCT05437692 2022-10-12

Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

19 enrolled

Gynecologic

Locally Advanced Cervical Cancer

NCT05575635 2022-10-12

Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC

40 enrolled

Rectal Neoplasms

NCT05507606 2022-08-19

Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations

Carcinoma, Non-Small-Cell Lung

NCT05472467 2022-07-25

IMCORT-2

35 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04398056 2022-07-06

Chemotherapy Plus Subsequent Loco-regional Radiotherapy Combined With Toripalimab in the De Novo Metastatic Nasopharyngeal Carcinoma

22 enrolled

Nasopharyngeal Carcinoma

NCT05422183 2022-06-16

Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer

20 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial

NCT05399394 2022-06-01

FOLRT

Pancreatic Neoplasms

NCT05360979 2022-05-04

A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC

42 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05311189 2022-04-05

Study of HLX10, Trastuzumab and Chemotherapy in First-line Treatment of HER2-positive Recurrent/Metastatic Gastric Cancer

40 enrolled

HER2-positive Gastric Cancer

NCT05298020 2022-03-28

Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer

20 enrolled

Advanced Pancreatic Cancer

NCT04690686 2022-03-08

Immunopheresis Alone or in Combination With Paclitaxel or Atezolizumab in Non-small Cell Lung Cancer (NSCLC).

24 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05243355 2022-02-17

Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC

46 enrolled

Squamous Non-small Cell Lung Cancer

NCT05241132 2022-02-15

Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary

27 enrolled

Tumor-Agnostic

Neoplasms

NCT05183958 2022-01-11

A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer

118 enrolled

Esophageal Neoplasms

NCT05184946 2022-01-11

Clinical Study of Camrelizumab Combined With SOX in the Adjuvant Treatment of Advanced Gastric Adenocarcinoma or Gastric Esophageal Junction Adenocarcinoma

72 enrolled

Stomach Neoplasms

NCT05174325 2021-12-30

Effectiveness of Neoadjuvant Chemotherapy Combined With PD-1 Monoclonal Antibody in the Treatment of Operable Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

NCT05170581 2021-12-28

Clinical Study of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT05170594 2021-12-28

A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer

60 enrolled

Gynecologic

Ovarian Neoplasms

NCT05136768 2021-11-29

LM-HNSCC

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis

NCT04291092 2021-09-10

Camrelizumab Combined With Local Treatment in NSCLC Patients With BM

63 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04275986 2021-07-07

Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma

56 enrolled

Esophageal Squamous Cell Carcinoma

NCT01676259 2021-07-02

PROTACT

80 enrolled

Neoplasms, Pancreatic Neoplasms

NCT04888806 2021-05-17

A Trial of Camrelizumab Combined With Microwave Ablation and Chemotherapy in the Treatment of Colorectal Cancer Liver Metastasis/Pulmonary Metastasis

37 enrolled

Colorectal Cancer Metastatic

NCT04826679 2021-04-01

Neoadjuvant Camrelizumab in Combination With Cisplatin and Nab-paclitaxel in Resectable HNSCC

53 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04136600 2020-12-30

EGFR Monoclonal Antibody for Advanced Gastric Cancer

100 enrolled